Prognostic Significance of CK5/6 and GATA3 Expression in Recurrent Urothelial Carcinoma
Salvato in:
| Pubblicato in: | Cancers vol. 17, no. 19 (2025), p. 3267-3289 |
|---|---|
| Autore principale: | |
| Altri autori: | , , , , , |
| Pubblicazione: |
MDPI AG
|
| Soggetti: | |
| Accesso online: | Citation/Abstract Full Text + Graphics Full Text - PDF |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| Abstract: | Background/Objectives: The study aimed to determine whether the expression of CK5/6 and GATA3 is altered in UCa recurrences and to evaluate disease-free survival (DFS) and overall survival (OS) according to CK5/6 and GATA3 expression. Methods: A retrospective study was performed in 77 patients with UCa. Surgery was performed in 35 patients. UCa recurrence was observed in 75% of patients. An immunohistochemical assessment of CK5/6 and GATA3 was performed in the primary and recurrent UCa groups. Results: CK5/6(+) in primary UCa was associated with a 73% probability of CK5/6(+) recurrence (p = 0.000005) and incidence at a younger age. CK5/6(−) in primary UCa was associated with an 84% probability of CK5/6(−) recurrence (p = 0.000005) and incidence at older age. A higher probability of UCa GATA3(+) recurrence was a significant independent factor associated with longer OS (p = 0.015). A greater probability of UCa CK5/6(+) recurrence was a significant independent factor associated with shorter OS (p = 0.044). Patients with CK5/6(+)-only UCa recurrences had significantly worse OS compared to UCa patients with at least one CK5/6(−) recurrence. Conclusions: 1. CK5/6 and GATA3 in UCa recurrences may differ from CK5/6 and GATA3 expression in primary UCa. Intensified oncological surveillance is suggested for patients with recurrent CK5/6(+) 2. Patients with at least one UCa CK5/6(−) recurrence have better prognosis compared to patients with only CK5/6(+) recurrences. |
|---|---|
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers17193267 |
| Fonte: | Biological Science Database |